2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03068754 (ClinicalTrials.gov)	June 22, 2017	23/2/2017	Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)	A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acth ...	Amyotrophic Lateral Sclerosis	Drug: Acthar;Drug: Placebo	Mallinckrodt	NULL	Terminated	18 Years	75 Years	All	143	Phase 2/Phase 3	United States;Argentina;Canada;Chile;Colombia;Mexico;Peru
2	NCT01906658 (ClinicalTrials.gov)	July 2013	15/7/2013	A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclero ...	A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclero ...	Amyotrophic Lateral Sclerosis	Drug: Repository corticotropin injection	Mallinckrodt	NULL	Completed	18 Years	80 Years	All	43	Phase 2	United States

First Previous1Next Last